Reprico, Labymed, J.J. Cohen, Novartis and Nipro Medical Corporation are some of the firms supplying medicines to public health institutions in the region.
Figures from the information system, "Public Purchases in the Health Sector" developed by the Trade Intelligence area of CentralAmericaData, details the list of companies favored with contracts to provide pharmaceutical products and medical supplies in tenders published between July 2017 and June 2018, by the several Ministries of Health and Social Security of Central American countries.
From January to November 2017, countries in the region imported $264 million worth of pharmaceutical products from Mexico, and 50% was acquired by companies in Panama.
Figures from the information system "Trade between Central America and Mexico", compiled by the Business Intelligence Unit at CentralAmericaData : [GRAFICA caption = "Click to interact with graph"]
Products, services, and medical, pharmaceutical and hospital technology equipment will be exhibited from October 19th to 20th at the Atlapa Convention Center.
The EXPO MEDICA PANAMÁ 2017 event will bring together companies from the pharmaceutical, medical, health and sports industries.
Participating companies will explore business opportunities and showcase beauty, sports, and gym products, among other things.
Between 2008 and 2013 the income generated by sales in pharmacies established in the country grew by 61% reaching $405 million last year.
The four strongest and most competitive market chains have opened new points of service have expanded their investments and plan to give the same continuity in 2015, despite the fact that a slight reduction in the historical rate of growth in the sector is expected, of approximately 2%.
From August 20th to 22nd the Ministries of Health will be jointly negotiating the purchase of international pharmaceutical drugs.
Medicines for the treatment of diabetes and cancer, kidney transplant processes, anticonvulsants, cardiovascular conditions and contraceptives are part of the products to be purchased by governments jointly in order to achieve better prices "... compared to other providers in the region."
Joint price negotiations for the purchase of medicines has led to better management of the budget of the Ministries of Health in countries in the region.
Since 2010 the Council of Ministers of Health of Central America and the Dominican Republic (COMISCA) has been negotiating the price and then each country makes its purchase from pharmaceutical manufacturers.